TAKHZYRO is a prescription medicine used to prevent hereditary angioedema (HAE) attacks in patients 2 years and older. Your long-term prevention starts here. See Safety and Allergy …

TAKHZYRO is an injection taken under the skin. Do not take TAKHZYRO without being trained by a healthcare professional. Read details on dosage and administration. See Safety and Allergy …

Learn about the studies and side effects to find out if TAKHZYRO is right for you. See Safety and Allergy information.

TAKHZYRO is clinically proven to help prevent HAE attacks, and patients experienced long-term freedom from attacks for an average of 14.8 months. 1,2 Evaluated in a 6.5-month study and a …

Learn about dosing of TAKHZYRO for adult, adolescent, and pediatric patients. See Important Safety information and Allergy information.

Help prevent attacks before they happen.* Consider preventive treatment with TAKHZYRO. TAKHZYRO is recommended by the 2020 US Hereditary Angioedema Association (HAEA) …

Understand why HAE attacks occur, and how TAKHZYRO affects kallikrein activity. See Safety and Allergy information.

Takeda Patient Support is a free program offering tailored support for TAKHZYRO. Here are details on the support and resources available. See Safety and Allergy information.

Explore the clinical study results on TAKHZYRO for hereditary angioedema. Read about the study details and impacts on adults and children. See Safety and Allergy information.

Appeals process resources. If a PA is denied, you can use these templates during the appeals process. Takeda Patient Support can also answer questions your office has about the denials …